CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 31 filers reported holding CHEMBIO DIAGNOSTICS INC in Q1 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $0 | – | 1,700 | -26.4% | 0.00% | – |
| Q4 2022 | $0 | – | 2,310 | -6.2% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 2,462 | -36.2% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 3,856 | -4.0% | 0.00% | – |
| Q1 2022 | $2,000 | -90.5% | 4,018 | -83.7% | 0.00% | -100.0% |
| Q4 2021 | $21,000 | -87.2% | 24,624 | -69.8% | 0.00% | -85.7% |
| Q3 2021 | $164,000 | +16300.0% | 81,518 | +6170.6% | 0.01% | – |
| Q2 2021 | $1,000 | -93.8% | 1,300 | -81.4% | 0.00% | -100.0% |
| Q1 2021 | $16,000 | -56.8% | 7,000 | -59.1% | 0.00% | -50.0% |
| Q4 2020 | $37,000 | -28.8% | 17,099 | -25.8% | 0.00% | -33.3% |
| Q3 2020 | $52,000 | -35.0% | 23,050 | -39.1% | 0.00% | -40.0% |
| Q2 2020 | $80,000 | – | 37,824 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Penbrook Management LLC | 348,960 | $1,225,000 | 0.88% |
| PERKINS CAPITAL MANAGEMENT INC | 289,680 | $1,017,000 | 0.59% |
| Newbridge Financial Services Group, Inc. | 87,185 | $306,000 | 0.22% |
| FRIESS ASSOCIATES LLC | 144,084 | $506,000 | 0.20% |
| Union Square Park Capital Management, LLC | 75,000 | $263,000 | 0.09% |
| PERRITT CAPITAL MANAGEMENT INC | 30,651 | $108,000 | 0.06% |
| Ikarian Capital, LLC | 219,109 | $769,000 | 0.03% |
| GAGNON SECURITIES LLC | 48,072 | $169,000 | 0.03% |
| SEGALL BRYANT & HAMILL, LLC | 703,826 | $2,475,000 | 0.02% |
| Phocas Financial Corp. | 30,000 | $105,000 | 0.01% |